More stories

  • in

    Boeing slashes losses as CEO touts ‘our turnaround year’

    Boeing slashed its quarterly losses as sales jumped after it delivered the most airplanes since 2018.
    The aerospace giant lost $176 million in the three months ended June 30, down from $1.09 billion a year earlier.
    Boeing executives will host an earnings conference call at 10:30 a.m. ET.

    The nose cone of a Boeing 787 being displayed on the tarmac during the Paris Air Show at Le Bourget Airport, outside Paris, June 25, 2023.
    Nicolas Economou | Nurphoto | Getty Images

    Boeing slashed its quarterly losses as sales jumped after it delivered the most airplanes since 2018, the clearest sign yet of improvement at the manufacturer that has swung from crisis to crisis for years.
    Here’s how Boeing performed in the second quarter, compared with estimates compiled by LSEG:

    Loss per share: $1.24 adjusted vs a loss of $1.48 expected
    Revenue: $22.75 billion vs $21.84 billion expected

    The aerospace giant lost $176 million in the three months ended June 30, down from $1.09 billion a year earlier. Revenue rose 35% to $22.75 billion from $16.87 billion. Adjusting for one-time items, Boeing reported a loss of $433 million or $1.24 a share, better than the loss analysts expected.
    “Change takes time, but we’re starting to see a difference in our performance across the business,” CEO Kelly Ortberg said in a note to staff outlining improvements across Boeing’s businesses.
    “If we continue to tackle the important work ahead of us and focus on safety, quality and stability, we can navigate the dynamic global environment and make 2025 our turnaround year,” he said.
    Boeing has been getting better by many metrics under Ortberg, a former aerospace executive and engineer who took the top job last August. Its airplane deliveries have improved, its production has become more stable and even once-critical airline CEOs have praised Boeing’s leadership.
    Boeing burned through $200 million in the second quarter, down from more $4.3 billion in the same period of 2024, which the company had expected would be a pivotal year for the plane maker until a door plug blew out of one of its packed Max 737 9 planes several minutes into the flight, renewing federal scrutiny on the company and hobbling production.

    In the second quarter of this year, sales in Boeing’s commercial airplane unit rose 81% from a year ago to $10.87 billion, and its negative operating margin more than halved to 5.1%.
    Boeing has increased output of its 737 Max aircraft to 38 a month, the Federal Aviation Administration’s limit after the January 2024 door plug near catastrophe. Ortberg earlier this year said the company would seek FAA approval at some point this year to go beyond that limit.

    Read more CNBC airline news

    For the three months ended June 30, Boeing handed over 150 airplanes. The last time it delivered that many planes in a second quarter was in 2018, which was also the last year Boeing posted an annual profit.
    The company still has challenges ahead. Boeing said Tuesday that the long-delayed certification of the Boeing 737 Max 7 and the Max 10, the smallest and largest members, respectively, of the Max family, likely won’t come this year as Ortberg forecast in May. 
    Also, Boeing’s defense unit has been riddled by charges in past quarters and, as of Sunday, could face a factory worker strike after employees voted down a new labor deal.
    Investors will look to Ortberg and the executive team on a 10:30 a.m. ET call on Tuesday for their outlook on further improved production, results and stability at a company that has been mired in crises since 2018, when the first of two deadly 737 Max crashes occurred.

    Don’t miss these insights from CNBC PRO More

  • in

    UnitedHealth says 2025 earnings will be worse than expected as high medical costs dog insurers

    UnitedHealth gave 2025 earnings guidance that fell well short of Wall Street’s expectations.
    The company and the broader insurance industry are grappling with higher medical costs in Medicare Advantage plans.
    The report adds to a growing string of setbacks for the company, which owns the nation’s largest and most powerful insurer and is often viewed as the industry’s bellwether.

    UnitedHealthcare signage is displayed on an office building in Phoenix, Arizona, on July 19, 2023.
    Patrick T. Fallon | Afp | Getty Images

    UnitedHealth Group on Tuesday issued a 2025 outlook that fell short of Wall Street’s expectations, as the company’s insurance unit continues to grapple with higher medical costs.
    Shares of UnitedHealth Group fell roughly 4% in premarket trading on Tuesday.

    The company anticipates it will post 2025 adjusted earnings of at least $16 per share, with revenue of $445.5 billion to $448 billion. Wall Street analysts had expected 2025 adjusted profit of $20.91 per share, and full-year revenue of $449.16 billion, according to consensus estimates from LSEG.
    On top of higher medical costs, the updated outlook removes about $1 billion from “previously planned portfolio actions” that the company is no longer pursuing, UnitedHealthcare CEO Tim Noel said during an earnings call on Tuesday. He did not provide specifics on those actions.
    UnitedHealth Group said it expects to return to earnings growth in 2026.
    The stock tumbled in May after the company suspended that 2025 guidance due to elevated medical costs and announced the abrupt departure of former CEO Andrew Witty. The report Tuesday adds to a growing string of setbacks for the company, which owns the nation’s largest and most powerful insurer, UnitedHealthcare, and is often viewed as the industry’s bellwether.
    The company expects its insurance unit’s 2025 medical care ratio — a measure of total medical expenses paid relative to premiums collected — to come in between 89% and 89.5%. A lower ratio typically indicates that a company collected more in premiums than it paid out in benefits, resulting in higher profitability.

    For the second quarter, that ratio increased to 89.4% from 85.1% during the year-earlier period, primarily due to medical costs. The company said health-care expenses during the quarter went up much faster than what it charged in premiums. On top of that, Medicare funding cuts also made things worse.
    Analysts had expected that ratio to come in at 89.3% for the quarter, according to StreetAccount estimates.
    UnitedHealth Group’s report signals that elevated medical costs in Medicare Advantage plans may not ease anytime soon for the broader health insurance industry. UnitedHealthcare, the insurance arm of UnitedHealth Group, is the nation’s largest provider of those privately run Medicare plans. 
    Higher expenses in Medicare Advantage plans have dogged insurers over the past year as more seniors return to hospitals to undergo procedures they had delayed during the Covid-19 pandemic, such as joint and hip replacements.
    “When we prepared our 2025 Medicare Advantage offerings back in the first half of 2024, we significantly underestimated the accelerating medical trend and did not modify benefits or plan offerings sufficiently to offset the pressures we are now experiencing,” Noel said during the call.
    Noel said physician and outpatient care collectively represented 70% of the pressure on medical costs so far this year. But inpatient care also accelerated through the second quarter, and the company expects it will account for a “relatively large portion of the pressure” over the full year, he added.
    UnitedHealthcare continues to see more patients use ER and observation stays, with more services being offered and bundled as part of each visit, Noel said.
    Here’s what UnitedHealth Group reported for the second quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: 

    Earnings per share: $4.08 adjusted vs. $4.48 expected
    Revenue: $111.62 billion vs. $111.52 billion expected

    The company posted net income of $3.41 billion, or $3.74 per share, for the quarter. That compares with net income of $4.22 billion, or $4.54 per share, during the year-earlier period.
    Excluding certain items, adjusted earnings were $4.08 per share for the quarter.
    UnitedHealth raked in $111.62 billion in revenue for the second quarter, up more than 12% from the same period a year ago due to growth within UnitedHealthcare and the company’s Optum unit. That segment includes Optum Health, which provides care and recommends providers, and pharmacy benefit manager Optum Rx.
    Despite higher medical costs, UnitedHealthcare generated $86.1 billion in revenue for the second quarter, up 17% from the same period a year ago. Analysts expected UnitedHealthcare to book $84.89 billion for the period, StreetAccount estimates said.
    While Optum Rx revenue jumped nearly 19% to $38.46 billion, Optum Health’s second-quarter revenue fell 7% year-over-year to $25.21 billion. The company’s ownership of an insurer, a pharmacy benefit manager and care providers has allowed it to dominate the industry, but the decline in Optum Health has drawn Wall Street’s attention.
    “We know Optum’s performance has not met expectations. We are refocused on fundamental execution to ensure we meet our potential to help make the health system work better for everyone,” said Dr. Patrick Conway, Optum’s CEO, in the release.
    The company expects the overall Optum unit to rake in 2025 sales of $266 billion to $265.7 billion.

    UnitedHealth’s response to DOJ investigation

    Notably, the report comes just days after UnitedHealth revealed it is complying with Department of Justice investigations into its Medicare billing practices. 
    Noel on Tuesday said the company is expanding its efforts to monitor its business practices and prevent extra costs for consumers.
    “We have stepped up our audit, clinical policy and payment integrity tools to protect customers and patients from unnecessary costs,” he said, adding that the company is using AI tools to improve patient and provider service experiences and save costs.
    During the earnings call, UnitedHealth Group’s new CEO Stephen Hemsley acknowledged that the company and other insurers face “continuing public controversy over long-standing practices.”
    He added that beyond the “environmental factors” affecting the entire sector, “we have made pricing and operational mistakes, and others as well. ”
    “They are getting the needed attention. Our critical processes, including risk status, care management, pharmaceutical services and others are being reviewed by independent experts and they will be reviewed every year and reported on,” he said. “And these processes can be reviewed at any time by outside stakeholders.
    Those experts include Analysis Group and FTI Consulting, Hemsley said. He added that the company expects the review to be completed by the end of the third quarter this year, with plans to release a first report on the findings in the fourth quarter.
    “While we believe in our oversight and the integrity of these processes, wherever they are determined to be at variance with prescribed practice, they will be promptly remediated and we will continue on this path,” he added.
    It marks UnitedHealth’s first earnings report under Hemsley, who is tasked with restoring investor confidence and turning around a struggling company that has continued to draw heavy public scrutiny in recent months. Shares of UnitedHealth Group are down more than 44% for the year, fueled in part by the DOJ’s investigations and its suspended outlook. 
    The company’s 2024 wasn’t any better. It grappled with the murder of UnitedHealthcare’s CEO, Brian Thompson, the torrent of public blowback that followed and a historic cyberattack that affected millions of Americans.  More

  • in

    Procter & Gamble beats estimates but warns tariffs will start to weigh on earnings

    Procter & Gamble on Tuesday reported quarterly results that beat Wall Street’s expectations, but introduced fiscal year 2026 guidance that included a $1 billion hit due to higher costs from tariffs.
    The company’s results come just one day after P&G announced Shailesh Jejurikar, its chief operating officer, would replace Jon Moeller as president and CEO, effective Jan. 1.
    CFO Andre Schulten said there will be mid-single-digit price increases affecting about a quarter of P&G’s items during the first quarter of fiscal 2026 due to tariffs and innovation.

    In this photo illustration, Procter and Gamble products Pepto Bismol and Charmin toilet paper are displayed on June 05, 2025 in San Anselmo, California.
    Justin Sullivan | Getty Images

    Procter & Gamble on Tuesday reported quarterly results that beat Wall Street’s expectations, but introduced fiscal year 2026 guidance that included a $1 billion hit due to higher costs from tariffs.
    “We grew sales and profit in fiscal 2025 and returned high levels of cash to shareowners in a dynamic, difficult and volatile environment,” said CEO Jon Moeller in a news release.

    CFO Andre Schulten said during a media call that there will be mid-single-digit price increases affecting about a quarter of P&G’s items during the first quarter of fiscal 2026 due to tariffs and innovation.
    P&G has invested significantly in the U.S., Schulten said, but some ingredients and materials are not available in the U.S. and continue to be imported. He said P&G can offset most of the tariff hit through productivity or sourcing changes, but some of the costs will be passed on through price increases.
    He described the consumer as “value-seeking” and “selective.”
    The consumer products giant, which owns brands such as Tide and Charmin, expects fiscal year 2026 sales growth of between 1% and 5% and earnings per share in the range of $6.83 to $7.09. The company said that factors in an estimated headwind 39 cents per share for fiscal 2026, or a 6% drag on core earnings per share growth, related to President Donald Trump’s tariffs, unfavorable commodity costs, higher net interest expense and its core effective tax rate.
    Wall Street analysts were expecting 2026 revenue growth of 3.1% and earnings per share of $6.99, according to LSEG.

    The company’s results come just one day after P&G announced Shailesh Jejurikar, its chief operating officer, would replace Moeller as the chief executive, effective Jan. 1. Moeller will transition to the role of executive chairman on that date.
    Here’s what Procter & Gamble reported for its fiscal fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

    Earnings per share: $1.48 vs. $1.42 expected
    Revenue: $20.89 billion vs. $20.82 billion expected

    P&G reported fiscal fourth-quarter net income of $3.62 billion, or $1.48 per share, up from $3.14 billion, or $1.27 per share, a year earlier.
    Net sales rose 2% to $20.89 billion. Organic sales, which strip out acquisitions, divestitures and foreign currency, also rose 2%.
    Schulten said during the media call that sales volume, which excludes pricing and therefore more accurately reflects demand, was in line with the prior year. P&G’s health care division reported a 2% decline in volume, while the beauty segment saw a 1% increase.
    The United States is P&G’s largest market, followed by China. Schulten said the China business grew 2% in terms of organic sales during the quarter, but total consumption in the market is still down about 2% compared with a year earlier.
    The fiscal 2026 guidance comes after P&G trimmed its outlook in April for the rest of the company’s fiscal 2025 year, citing consumer uncertainty and tariffs. Moeller said at the time that price hikes tied to tariffs would occur during the company’s fiscal 2026 year, which began this month.
    CFO Andre Schulten also said in April that tariffs would hurt P&G’s growth by a range of $1 billion to $1.5 billion per year.
    Both JPMorgan and Evercore downgraded PG earlier this month. The former predicted soft organic sales and the latter pointed to share losses within Amazon as a concern amid a growing shift toward online retail.
    Procter & Gamble shares were up about 2% in premarket trading Tuesday. As of Monday’s close, the company’s stock was down about 6% year to date. More

  • in

    Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook

    Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches and its drug pipeline. 
    The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster cancer drug Keytruda in 2028, and braces for the Trump administration’s planned tariffs on pharmaceutical imported into the U.S.
    Merck also posted second-quarter revenue that missed estimates and narrowed its full-year guidance.

    Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, April 8, 2025.
    Michael Nagle | Bloomberg | Getty Images

    Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches and its drug pipeline. 
    The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster cancer drug Keytruda in 2028. It also comes as drugmakers brace for President Donald Trump’s planned tariffs on pharmaceuticals imported into the U.S., which has prompted Merck and other companies to invest billions to boost their manufacturing footprints in the U.S. 

    Shares of the pharmaceutical giant fell roughly 3% in premarket trading on Tuesday.
    “Today, we announced a multiyear optimization initiative that will redirect investment and resources from more mature areas of our business to our burgeoning array of new growth drivers, further enable the transformation of our portfolio, and drive our next chapter of productive, innovation-driven growth,” said Merck CEO Rob Davis in prepared remarks for the company’s earnings call.
    He added that his confidence in Merck’s ability to navigate Keytruda’s loss of exclusivity increases with every new product launch, data readout and business deal. Davis said he sees that patent expiration “as more of a hill than a cliff, and I’m confident in our ability to grow over the long-term.”
    As part of the effort, Merck in July approved a new restructuring program that will eliminate certain administrative, sales and research and development positions. But the company will continue to hire employees in new roles across growth areas of its business. Merck will also reduce its global real estate footprint and continue to pare back its manufacturing network. 
    Merck expects actions under the restructuring program to generate around $1.7 billion in annual cost savings, most of which will kick in by the end of 2027. 

    The company expects pretax costs related to the restructuring program to be approximately $3 billion in total. For its second quarter, Merck recorded a $649 million charge related to the program. 
    Also on Tuesday, Merck reported second-quarter revenue that came in short of Wall Street estimates. It was the first time that metric had missed expectations since April 2021.
    While Keytruda sales grew during the period, Merck continued to see trouble with China sales of Gardasil, a vaccine that prevents cancer from HPV, the most common sexually transmitted infection in the U.S.
    In February, Merck announced a decision to halt shipments of Gardasil into China beginning that month and going through at least mid-2025. In prepared remarks, CFO Caroline Litchfield said the company will not resume shipments to China through at least the end of 2025, noting that inventories remain high and demand is still soft.
    The company also narrowed its full-year guidance. Merck now expects its 2025 adjusted earnings to come in between $8.87 and $8.97 per share. That compares to its previous outlook of $8.82 to $8.97 per share.
    Merck expects revenue for the year to come in between $64.3 billion and $65.3 billion, narrowed on both ends from its previous guidance of $64.1 billion to $65.6 billion. 
    Here’s what Merck reported for the second quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: 

    Earnings per share: $2.13 adjusted. That figure may not be comparable to estimates of $2.01.
    Revenue: $15.81 billion vs. $15.89 billion expected

    Merck said its guidance includes the previously announced $200 million estimated impact associated with the tariffs Trump has implemented to date. In April, the company said the expected tariff charge primarily reflects levies between the U.S. and China, but did not account for sector-specific pharmaceutical tariffs. 
    The outlook also includes one-time charges related to the company’s license agreements with Hengrui Pharma and LaNova, but not its recently announced acquisition of Verona Pharma. 
    The company posted net income of $4.43 billion, or $1.76 per share, for the quarter. That compares with net income of $5.46 billion, or $2.14 per share, during the year-earlier period. 
    Excluding acquisition and restructuring costs, Merck earned $2.13 per share for the second quarter. That includes a charge of 7 cents per share for closing the license agreement with Hengrui Pharma.
    Merck raked in $15.81 billion in revenue for the quarter, down 2% from the same period a year ago.

    Pharmaceutical, animal health sales

    Merck’s pharmaceutical unit, which develops a wide range of drugs, booked $14.05 billion in revenue during the second quarter. That’s down 2% from the same period a year earlier.
    Keytruda recorded $7.96 billion in revenue during the quarter, up just 9% from the year-earlier period. 
    That increase was driven by higher uptake of Keytruda for earlier-stage cancers and strong demand for the drug for metastatic cancers, which spread to other parts of the body, the company said. Analysts had expected the drug to see $7.9 billion in sales, according to StreetAccount estimates.  
    Gardasil generated sales of $1.13 billion for the quarter, down 55% from the same period a year ago due to lower demand in China. Analysts had expected Gardasil to book sales of $1.33 billion, StreetAccount estimates said. 
    The Chinese market makes up the majority of the blockbuster shot’s international revenue. Merck is hoping that Gardasil’s expanded approval for men ages 9 to 26 in China will help boost uptake of the vaccine.
    Sales of Gardasil in the U.S. increased 2% during the second quarter. 
    Meanwhile Merck’s newer drug Winrevair, which is used to treat a rare, deadly lung condition, recorded $336 million in sales for the quarter. Analysts had expected the drug to bring in $324.7 million, according to StreetAccount estimates.  
    Merck’s animal health division, which develops vaccines and medicines for dogs, cats and cattle, posted nearly $1.65 billion in sales, up 11% from the same period a year prior. The company said higher demand for livestock products and sales from Elanco’s aqua business, which it acquired last year, drove that growth. More

  • in

    With Trump pressure and a ‘new Lebanon,’ can Hezbollah’s shadow economy be dismantled?

    “Hezbollah finds itself in its greatest predicament since its foundation,” one regional expert told CNBC.
    Hezbollah makes money from industries like banking and construction, but also runs international drug trafficking and smuggling operations as far afield as Bulgaria and Argentina. Its revenues are estimated in the billions of dollars annually. 
    Following Israel’s aggressive assault – its most deadly since the 2006 war – Hezbollah’s leadership and financial infrastructure have been pushed to the brink.

    Vehicles transporting people who had fled southern Lebanon are slowed down by heavy traffic on the outbound road from Beirut, in the area of Khaldeh on November 28, 2024, a day after a cease fire between Israel and Hezbollah took hold. 
    Ibrahim Amro | Afp | Getty Images

    Up until a few months ago, the drive from Beirut’s international airport through the Lebanese capital city’s southern suburbs used to feature a stream of pro-Iranian and Hezbollah-themed propaganda. 
    Hassan Nasrallah, the charismatic former leader of the Iran-backed group who was killed in Beirut last year, stared down at you from billboards while you drove along Imam Khomeini Road, named after the late founder of Iran’s Islamic Republic. Images of Hezbollah leaders were interspersed with dramatic murals of fallen Iranian spy commander Qasem Soleimani. 

    Now many of those images have been replaced with western and local brands. In June dozens of those billboards along the highway instead featured Formula One racecar driver Lewis Hamilton advertising shaving products. 
    Many of the new posters also feature patriotic, unifying messages that replaced the formerly sectarian signage — an attempt by Lebanon’s new Prime Minister Nawaf Salam to encourage “A New Era for Lebanon,” just in time for the summer tourism boom the Mediterranean country is hoping for after months of war. 
    In this “new” Lebanon, Hezbollah is being forced to operate in the shadows — more than ever in the group’s over 40-year history. 
    The Iranian proxy, which controls several parts of Lebanon as a sub-state group and is designated a terrorist organization by Washington, has always looked for creative ways to evade U.S. sanctions. But since Israel’s aggressive assault – its most deadly since the 2006 war – Hezbollah’s leadership and financial infrastructure have been left in tatters. 
    “Hezbollah finds itself in its greatest predicament since its foundation. The Israeli war against Lebanon greatly hit the party and its infrastructures, assassinating the party’s senior military and political leaders including Secretary-General Hassan Nasrallah,” Joseph Daher, author of “Hezbollah: The Political Economy of Lebanon’s Party of God,” told CNBC. 

    “The regions majorly inhabited by the Shia population have been greatly targeted, destroying extensively civilian housing and infrastructures as well,” he said.

    A vehicle carries the coffins of former Hezbollah leaders Hassan Nasrallah and Hashem Safieddine, who were killed in Israeli airstrikes last year, during a public funeral ceremony, in Camille Chamoun Sports City Stadium, on the outskirts of Beirut, Lebanon, on Feb. 23, 2025. 
    Thaier Al-sudani | Reuters

    The group, whose political wing also holds seats in parliament, still wields significant political power in Lebanon, which last held parliamentary elections in 2022. Despite losing the most significant number of seats in the group’s political history, it still held tight to a 62-seat coalition in the 128-member parliament. 
    While Hezbollah “will not disappear because it has a strong, disciplined and organized political and militant structure, and benefits from the continued assistance of Iran,” the group “has become increasingly politically and socially isolated outside Lebanon’s Shia population,” Daher said.

    Outside the banking system 

    While Hezbollah receives much of its funding from Iran, it has also developed extensive international financial networks to bring in revenue. The group makes money from traditional industries like banking and construction, but it also runs smuggling, money laundering and international drug trafficking operations around the Middle East and as far afield as Bulgaria and Argentina. Its revenues are estimated in the billions of dollars annually. 

    FILE PHOTO: Lebanon’s Hezbollah leader Sayyed Hassan Nasrallah gestures as he addresses his supporters during a rare public appearance at an Ashoura ceremony in Beirut’s southern suburbs November 3, 2014. 
    Hasan Shaaban | Reuters

    Hezbollah’s parallel governance strategy, operating as both a political party and sub-state group, has enabled it to survive and grow as an armed group for decades.
    When Lebanese depositors were locked out of their savings in 2019 after a financial meltdown crippled the country and its currency, Hezbollah remained able to fund its base and illicit activities. It operated cash-only businesses and ran black market U.S. dollar exchanges. 
    This strategy will continue despite pressure on their finances, regional analysts say, due to the extreme difficulty of tracking informal, cash-only transactions.

    Lebanon’s economy “operates more than 60% on cash exchanges, the circulation of which the state cannot trace,” Daher said. “It is thanks to the segment of this cash in circulation that Hezbollah smuggles into Lebanon that it finances its activities and pays its employees and helps its popular base, alongside other sources of funding, both licit and illicit.” 
    However, the U.S. under President Donald Trump’s administration is placing renewed pressure on Lebanon’s new government to crack down on Hezbollah’s illicit activities.

    New government crackdowns

    In an apparent blow to Hezbollah’s funding operations, Lebanon’s central bank, the Banque Du Liban (BDL), issued a directive banning all financial institutions in the country from any dealings with Al-Qard al-Hasan — a Hezbollah-linked financial entity that provides local loans by taking gold and jewelry as collateral. It’s a tool by which Hezbollah cements support from the country’s Shiite population and gets more funding for its operations. Israel has specifically targeted Al-Qard al-Hasan facilities with airstrikes in the last year.  
    The BDL move was “ingenious,” said Matthew Levitt, a senior fellow at The Washington Institute and director of its counterterrorism and intelligence program, because Al-Qard al-Hasan has long been registered as a charity and thus was able to operate outside the Lebanese financial system, evading regulatory oversight.
    “Here, the BDL appears to have found a way to jump the gap and say, ‘whatever you are, people can’t provide services for you. You can’t bank, and anybody who does is violating the law,” Levitt said. 

    Black smoke rises above the Dahieh neighborhood after Israeli airstrikes on targets of Lebanese Hezbollah, widely believed to be the last of a series of strikes aimed at Hashem Safieddine, the likely successor of the assassinated previous Hezbollah leader Hassan Nasrallah, who Israel announced has now been killed, near the southeast corner of the international airport on October 8, 2024 in Beirut, Lebanon. 
    Scott Peterson | Getty Images

    Until recently, Hezbollah controlled almost all ports of entry in Lebanon, including the Beirut airport. Following Israel’s assault on the group, its airport is now under the control of the Lebanese government, which has fired staff linked to Hezbollah, detained smugglers, and implemented new surveillance technology.
    And while Tehran is still funding its proxy group, its transport routes to Lebanon are dramatically restricted after losing a key ally with the fall of the Bashar al Assad regime in Syria. Flights coming in from Iran and other locations meant to bring in material support for Hezbollah are being heavily inspected, experts told CNBC.
    “Cash transfers from abroad have been intercepted at the airport and border. We are talking about millions of dollars,” Daher said of the renewed security in the country. 

    ‘The window of opportunity is now’

    Many who want to see Hezbollah’s power dismantled say the time is now.
    “When you now have Iran under tremendous stress, and Lebanon overtly trying to crack down on Hezbollah’s ability to function as an independent militia – and trying to target the funding it needs to be able to do that – you have an interesting opportunity,” Levitt, who also served as deputy assistant secretary for intelligence and analysis at the U.S. Treasury Department, told CNBC in an interview.
    For the first time in decades, both the prime minister and president of Lebanon are interested in asserting monopoly over the use of force in the country, he added. 
    “They’re interested in securing the much, much needed international aid that Lebanon needs to get out of the economic crisis, and they’re interested in not saying no to the Trump administration.”
    But it’s not that easy. The group, long described as the most powerful non-state organization in the Middle East, is still loyally followed by hundreds of thousands of people who rely on it for social services and ideological leadership — and it remains well-armed. 
    Notably, no one is officially demanding Hezbollah disband or cease to exist entirely. Trump’s envoy to the region Tom Barrack recently demanded Hezbollah lay down its weapons, a proposition the group has rejected. 
    “Hezbollah’s not going to disarm because you ask them nicely,” Levitt said. “But we have to enable the government of Lebanon to do this, give them the capability to do it, and have their back when they do it.”
    That requires a combination of carrots and sticks, former U.S. officials say – ironically, tools that have in many cases been weakened by the shrinking of U.S. government resources under the Trump administration. 

    Alexander Zerden, principal at Washington-based risk advisory firm Capitol Peak Strategies who formerly served at the U.S. Treasury Department’s Office of Terrorism and Financial Intelligence, outlined some of those potential approaches.
    “On the offensive side, the U.S. can and will likely continue to target Hezbollah financial networks inside and outside of Lebanon. The U.S. will seek to deny Hezbollah access to Syria, including lucrative reconstruction contracts,” Zerden said.
    “On the incentive side, direct tools are more limited with reductions in diplomacy and development capabilities,” he noted – one example of that being the gutting of USAID, which served as a powerful diplomatic vehicle. “However,” he added, “there appears to be space for the U.S. to support economic reforms.”
    For Ronnie Chatah, a Lebanese political analyst and host of The Beirut Banyan podcast, what’s truly needed is international pressure that would push Iran to relinquish its involvement in Lebanon. 
    “What has not yet shifted in Lebanon’s favor is the international aspect, meaning finding a way for Iran to abandon Lebanon that I think can only happen by strategic diplomacy,” said Chatah, whose father, a former Lebanese finance minister, was killed in a suspected Hezbollah assassination plot.
    “If the Trump administration wants peace the way it says repeatedly, if Donald Trump wants the Nobel Peace Prize too, there has to be some way forward for Lebanon to take the spotlight and to find a peaceful resolution that in some ways satisfies Iran’s terms,” he told CNBC from Beirut.
    What’s been done so far by both the U.S. and Lebanese governments is important, but will not ultimately break Hezbollah’s power in the country, Chatah warned.
    “The window of opportunity is now. It’s not tomorrow, and unfortunately, it’s a closing window,” he said. “The intent is not enough. Whether it’s by the Trump administration or even whether it’s by the Lebanese president, the intention is not enough.” More

  • in

    Barclays second-quarter profit beats estimates as investment banking revenues swell

    Barclays is the latest bank to beat estimates and report higher revenue from its investment banking this quarter, after U.S. tariffs triggered intense market volatility.
    Pre-tax profit at the British lender came in at £2.5 billion, versus an analyst estimate of £2.23 billion, while revenues were in-line with forecasts at £7.2 billion.
    Barclays is meanwhile delivering on its cost-reduction targets, CEO C.S. Venkatakrishnan said.

    One Churchill Place skyscraper, the Barclays Plc headquarters, at Canary Wharf in London, U.K., on Thursday, Jan. 7, 2021. 
    Bloomberg | Bloomberg | Getty Images

    British bank Barclays on Tuesday beat profit expectations and announced a £1 billion ($1.33 billion) share buyback as market volatility boosted investment banking revenues.
    Pre-tax profit beat estimates at £2.5 billion ($3.34 billion) in the second quarter, compared with a mean LSEG forecast of £2.23 billion. Group revenues met analyst projections of £7.2 billion.

    Other highlights:

    Return on Tangible Equity hit 13.2% at the end of the first half, versus 14% in the first quarter.
    Earnings per share rose to 11.7p from 8.3p.
    CET1 capital ratio, a measure of bank solvency, was 14%, compared with 13.9% in the March quarter.

    Investors have been watching the performance of the lender’s sharpened investment banking unit, which posted income of £3.3 billion in the three months to June, up 10% year-on-year. Higher net interest and trading income offset a fall in advisory fees and commissions at the unit.
    Barclays is the latest bank to report higher earnings boosted by markets trading in a quarter that included the turbulent fallout from U.S. President Donald Trump’s tariff policies announced in April. Global stocks plunged before staging a massive rebound, with Europe recovering ahead of the U.S. Currency markets have also been roiled, with the U.S. dollar suffering steep declines.
    Deutsche Bank last week beat profit expectations, helped by strong performance in fixed income and currencies. Stateside, JPMorgan Chase and Morgan Stanley have been among those to report higher trading revenues.
    The investment banking division is the traditional backbone of Barclays’ revenues and a target of cost reductions under CEO C.S. Venkatakrishnan unveiled in February 2024. It saw further changes in recent months, amid the hire of former Deutsche Numis exec Alex Ham as global chairman, a report of plans to cut more than 200 jobs and a report the bank is tapping consultancy McKinsey to identify further room for cost cutting.

    Venkatakrishnan said in a statement Tuesday: “We remain on track to achieve the objectives of our three-year plan, delivering structurally higher and more stable returns for our investors.” At its mid-point, the strategy has delivered half its target income growth, over half its U.K. risk weighted assets growth and two-thirds of its planned £2 billion in cost savings, he added.
    Adding to Barclays’ challenges, pending changes in U.S. capital leverage rules could unleash further competition stateside — where the bank has had a significant presence since acquiring Lehman Brothers’ investment banking and capital markets businesses — in the British lender’s area of strength of debt markets.
    Domestically, Barclays faces a shifting British banking landscape, where Spanish titan Santander has doubled down on its U.K. presence with the early-July acquisition of British high street lender TSB from Sabadell, and investors are watching for any change in strategic tack from NatWest, which returned to private ownership at the end of May.
    Sticky inflation could meanwhile position the Bank of England to take a cautious approach to rate cuts, impacting the net interest margin of U.K. banks. More

  • in

    Spirit Airlines to furlough 270 pilots, demote more than 100 others as it prepares to cut flights

    Spirit will furlough 270 pilots, effective Nov. 1, as it prepares for a smaller flight schedule.
    The carrier emerged from Chapter 11 bankruptcy in March, but the industry is now facing weaker-than-expected demand for coach-class tickets.
    The airline furloughed hundreds of pilots last year.

    A Spirit Airlines Airbus A320 taxis at Los Angeles International Airport after arriving from Boston on September 1, 2024 in Los Angeles, California.
    Kevin Carter | Getty Images News | Getty Images

    Spirit Airlines said Monday that it will furlough 270 pilots this fall as the carrier prepares for a smaller off-season schedule to try to find its financial footing.
    The airline will also downgrade 140 pilots from captain to first officer, according to a note to aviators from the Air Line Pilots Association, their union. Those downgrades take effect on Oct. 1.

    “We know how hard this news hits, and there’s no dressing that up. Spirit continues to shrink, and with it, the value of pilot seniority and Spirit careers continues to erode,” said Ryan Muller, a captain and the chairman of Spirit’s ALPA chapter.
    The furloughs take effect on Nov. 1 “to better align staffing with our flight schedule,” the airline said.

    Read more CNBC airline news

    Spirit emerged from Chapter 11 bankruptcy in March and has been trying to win over customers with more upscale travel options, which have fared better than the bare-bones coach tickets Spirit has been known for for years.
    “We are taking necessary steps to ensure we operate as efficiently as possible as part of our efforts to return to profitability,” Spirit said in a statement to CNBC.
    Airlines across the industry have said demand has been softer this year, particularly in off-peak travel periods.

    “We recognize the weight of this decision and are committed to treating all affected Team Members with compassion and respect during this process,” Spirit said.
    Spirit also announced hundreds of pilot furloughs last year as it approached its bankruptcy filing. More

  • in

    JPMorgan says fintech middlemen like Plaid are ‘massively taxing’ its systems with unnecessary pings

    JPMorgan Chase said the fintech companies that help financial apps connect with traditional checking accounts are flooding the bank’s systems with unnecessary data requests.
    Of 1.89 billion data requests from middlemen hitting its systems in June, only 13% were initiated by a customer for transactions, according to an internal JPMorgan memo seen by CNBC.
    The majority of data pulls, known as API calls, were for purposes ranging from helping fintech companies improve their products or prevent fraud to other efforts including harvesting data for sale, said a person with knowledge of the memo.

    Jamie Dimon, chief executive officer of JPMorgan Chase & Co., at the Institute of International Finance (IIF) during the annual meetings of the IMF and World Bank in Washington, DC, US, on Thursday, Oct. 24, 2024. 
    Kent Nishimura | Bloomberg | Getty Images

    JPMorgan Chase said fintech middlemen — the companies that have helped a new generation of financial apps connect with traditional checking accounts — are flooding the bank’s systems with unnecessary data requests.
    “Aggregators are accessing customer data multiple times daily, even when the customer is not actively using the app,” a JPMorgan systems employee wrote last week in an internal memo to retail payments head Melissa Feldsher. “These access requests are massively taxing our systems.”

    Of 1.89 billion data requests from middlemen hitting JPMorgan’s systems in June, only 13% were initiated by a customer for transactions, according to the memo, which was seen by CNBC.
    The majority of data pulls, known as API calls, were for purposes ranging from helping fintech companies improve their products or prevent fraud to other efforts including harvesting data for sale, said a person with knowledge of the memo who declined to be identified amid talks between JPMorgan and the fintechs.
    JPMorgan, the biggest U.S. bank by assets, is preparing to charge the middlemen new fees for access to systems that it says are increasingly costly to maintain. Negotiations between JPMorgan and the fintech middlemen are ongoing, but the new fees could start as soon as October, said people with knowledge of the matter.
    The bank’s move could lead to upheaval in the fintech ecosystem, which flourished as aggregators including Plaid and MX connected traditional banks with newer arrivals. The API access had been free for years, allowing middlemen to profit from selling connectivity to fintechs that in turn offered accounts with no-fee checking or trading services.
    The situation changed in May after the Consumer Financial Protection Bureau filed a motion in support of a banking industry lawsuit seeking to end the so-called “open banking” rule.

    That rule, finalized by the Biden-era CFPB in the waning months of that administration, mandated that banks had to provide data to authorized parties for free. A week after the rule’s passage, JPMorgan CEO Jamie Dimon called on bankers to “fight back” against what he said were unfair regulations.

    Surging volumes

    News this month that JPMorgan was planning to charge for customer data, first reported by Bloomberg, led to accusations from venture capital investors and fintech and crypto executives that JPMorgan was engaging in “anti-competitive, rent-seeking behavior” by putting up paywalls to customer data.
    But JPMorgan says it bears the rising costs from maintaining the infrastructure needed for the surge in volumes, as well as elevated fraud claims linked to payments made in the fintech ecosystem.
    The total volume of API calls received by JPMorgan has more than doubled in the past two years, according to the memo.
    Transactions involving money sent over electronic ACH transactions were 69% more likely to result in fraud claims if they involved data middlemen, according to the memo.
    JPMorgan saw about $50 million in fraud claims from ACH transactions initiated through aggregators, a figure the bank expects to triple within 5 years, the memo said.
    Among the 13 fintech companies tracked in the bank’s memo, more than half of all June activity, with 1.08 billion API requests, came from a single company. Though the firms aren’t named, CNBC has learned that the largest player represented in the data is Plaid.
    JPMorgan’s data shows that just 6% of Plaid’s API calls were initiated by customers.

    Plaid co-founders William Hockey and Zach Perret
    Source: Plaid

    Granting access

    Plaid said in a statement to CNBC that this figure “misrepresents how data access works” because all activity begins when customers grant permission to fintech companies when they sign up for accounts. Of course, many customers don’t closely read the lengthy “Terms and Conditions” pages that contain data-sharing disclosures before opening new accounts.
    “Calling a bank’s API when a user is not present once they have authorized a connection is a standard industry practice supported by all major banks in order for consumers to get critical alerts for overdraft fees or suspicious activity,” Plaid told CNBC.
    Plaid also said that JPMorgan’s claims of higher fraud among aggregators were “misleading,” though it didn’t elaborate.
    “It is not surprising that the volume of data access is increasing alongside demand from consumers for financial tools that are smarter, faster, and more tailored to their needs,” Plaid said.
    “To be clear, we believe it is essential that the data sharing ecosystem works for everyone, including consumers, fintech developers, and financial institutions – many of whom leverage open banking in their own products,” the company said.
    The proposed fee schedules circulated by JPMorgan could result in Plaid paying $300 million in new annual fees, according to a Forbes report.
    The rest of the companies tracked in the JPMorgan document are far smaller entities; only four other middlemen registered more than 100 million monthly API calls.

    Bid-ask spread

    If the Biden-era “open banking” rule is struck down by the courts, the main question is not whether the middlemen will have to pay for data but how much they will have to pay.
    The back-and-forth between JPMorgan and the middlemen is a private process, spilling into public view, to arrive at a new reality that is acceptable to all.
    JPMorgan has had productive conversations with several data aggregators who acknowledge that they can change the way they pull data if it is no longer free, according to a person with knowledge of the negotiations.
    “I think both sides fully acknowledge there are things they could do to right-size call volume,” this person said. More